Zimmer Biomet management check

ZBH · Health Care · Health Care Equipment · CEO Mr. Tornos

Filings as of

49
Management score, ranked 428th of 487 · 51st of 60 in Health Care2 good · 4 to watch · 1 flaggedStrongest: clean books · Weakest: owner returns · Best and worst run in Health Care →

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$63Peers$127

    What $100 became since fiscal 2021

    016th
    Detail

    $100 invested at the start of fiscal 2021 grew to $63, against $127 for the peer group the company picked itself.

  • Watch

    Does pay follow performance?

    Pay only loosely tracked returns20212025

    Pay actually paid $100 value, each on its own scale

    5113th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.02 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Watch

    What does the CEO cost owners?

    2.3% of net income

    $16.1m pay · $705.0m net income, FY2025

    0.1%1%3%10%
    2025th
    Detail

    $16.1m of reported pay in fiscal 2025, against $705.0m of net income.

  • Watch

    Do they own the stock?

    Insiders are selling

    6 mo: ▲ $0 bought · ▼ $1.2m sold

    ——
    Detail

    3 insiders sold $1.2m in the last six months and none bought.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 210m2025 · 199m

    Diluted shares −2.7% a year; flagged above +2%

    0%10%20%

    Stock pay 1.1% of revenue

    8375th
    Detail

    Diluted shares changed -2.7% a year over the last three fiscal years. Stock-based pay was 1.1% of revenue in the latest year.

  • Watch

    Is leadership stable?

    2 CEOs in the pay table

    9 filings under 8-K 5.02 in 3 years

    0101420+

    CEOs: Bryan Hanson, Mr. Tornos

    4018th
    Detail

    CEOs in the pay table: Bryan Hanson, Mr. Tornos. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed April 1, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$10.3m$20.5m$10020212022202320242025$63$127

Pay tied most to consolidated constant currency revenue

Other key measuresConsolidated constant currency revenueConsolidated free cash flowAdjusted operating profitAdjusted EPS growth

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Mr. Tornos$16.1m$12.6m$6.1m$63$127$705.0m
2024—$15.0m$9.2m$3.9m$73$117$903.8m
2023Bryan Hanson$12.8m$10.3m$5.0m$83$106$1.0bn
2022—$16.4m$20.5m$4.7m$87$97$231.4m
2021—$15.0m$0$4.2m$83$119$401.6m

Insiders and the CEO's stakeSelling

3 insiders sold $1.2m in the last six months and none bought.

Open-market trades by officers and directors since May 21, 2026.

  • SoldKevin R ThornalGrp Pres-Global Business$529kSep 11, 2026
  • SoldSang YiGroup President, Asia Pacific$413kMay 29, 2026
  • SoldChad F PhippsSee remarks below.$295kSep 4, 2026

Leadership and governance on file

20222023202420252026Leadership 11Votes 5
All 11 filings

Latest shareholder vote results: May 27, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $3.2bn returned to owners in buybacks and dividends, 97% of net income, and $472.0m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$532.0m$1.1bn20212022202320242025Shares210m210m210m204m199m
Show the figures
Fiscal year20212022202320242025
Revenue$6.8bn$6.9bn$7.4bn$7.7bn$8.2bn
Net income$401.6m$231.4m$1.0bn$903.8m$705.1m
Stock-based pay$76.0m$105.0m$99.8m$101.0m$90.2m
Buybacks—$126.4m$692.2m$868.0m$487.0m
Dividends$200.1m$201.2m$200.9m$196.0m$190.3m
Diluted shares210m210m210m204m199m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.